tiprankstipranks
Trending News
More News >
Promising Potential of Protagonist Therapeutics’ Icotrokinra in Psoriasis Treatment: A Buy Recommendation by Roger Song
PremiumRatingsPromising Potential of Protagonist Therapeutics’ Icotrokinra in Psoriasis Treatment: A Buy Recommendation by Roger Song
18d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
Protagonist Therapeutics price target raised to $70 from $58 at Wedbush
Premium
The Fly
Protagonist Therapeutics price target raised to $70 from $58 at Wedbush
2M ago
Promising Potential of Protagonist Therapeutics’ Icotrokinra in Psoriasis Treatment: A New Benchmark for Oral Therapies
PremiumRatingsPromising Potential of Protagonist Therapeutics’ Icotrokinra in Psoriasis Treatment: A New Benchmark for Oral Therapies
2M ago
3 Best Stocks to Buy Now, 3/10/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 3/10/2025, According to Top Analysts
2M ago
Protagonist Therapeutics: Buy Rating Backed by Promising Phase 3 Results and Market Potential of Icotrokinra
Premium
Ratings
Protagonist Therapeutics: Buy Rating Backed by Promising Phase 3 Results and Market Potential of Icotrokinra
2M ago
Protagonist Therapeutics: Buy Rating Affirmed on Rusfertide’s Phase 3 Success and Market Potential
PremiumRatingsProtagonist Therapeutics: Buy Rating Affirmed on Rusfertide’s Phase 3 Success and Market Potential
2M ago
Protagonist Therapeutics: Strong Buy Rating Backed by Promising Phase 3 Results and Robust Financial Outlook
Premium
Ratings
Protagonist Therapeutics: Strong Buy Rating Backed by Promising Phase 3 Results and Robust Financial Outlook
2M ago
Buy Rating for Protagonist Therapeutics: Strong Potential in Rusfertide and Strategic Partnerships
Premium
Ratings
Buy Rating for Protagonist Therapeutics: Strong Potential in Rusfertide and Strategic Partnerships
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100